Literature DB >> 26900277

Liver Transplantation After Bone Marrow Transplantation for End Stage Liver Disease with Severe Hepatopulmonary Syndrome in Dyskeratosis Congenita: A Literature First.

Shyam Sunder Mahansaria1, Senthil Kumar1, Kishore G S Bharathy1, Sachin Kumar2, Viniyendra Pamecha1.   

Abstract

Dyskeratosis congenita is a multisystem genetic disorder. Although hepatic involvement is reported in about 7% of patients with dyskeratosis congenita, it is not well characterized and often attributed to hemochromatosis from frequent blood transfusions. A few case reports describe cirrhosis and hepatic cell necrosis in affected individuals in autosomal dominant pedigrees. Bone marrow failure and malignancies are the principal causes of death in dyskeratosis congenita. We describe the first case of living donor liver transplantation, in dyskeratosis congenita for decompensated cirrhosis with portal hypertension. The patient also had associated severe hepatopulmonary syndrome, interstitial lung disease, bilateral hip replacement for avascular necrosis of the head of femur, and a past history of bone marrow transplantation for bone marrow failure.

Entities:  

Keywords:  BMF, bone marrow failure; DKC, dyskeratosis congenita; HPS, hepatopulmonary syndrome; LDLT, living donor liver transplantation; MAA, microaggregated albumin scan; PHT, portal hypertension; SCE, saline contrast echocardiography; chronic liver disease; dyskeratosis congenita; hepatopulmonary syndrome; liver transplantation; microaggregated albumin scan

Year:  2015        PMID: 26900277      PMCID: PMC4723656          DOI: 10.1016/j.jceh.2015.10.003

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  13 in total

Review 1.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

2.  Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation.

Authors:  Miguel R Arguedas; Gary A Abrams; Michael J Krowka; Michael B Fallon
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

3.  A case of dyskeratosis congenita with portal hypertension associated with jugular venous anomaly.

Authors:  Yusuf Yazgan; Levent Demirtürk; Melih Ozel; Cinar Başekim
Journal:  Turk J Gastroenterol       Date:  2006-03       Impact factor: 1.852

4.  Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation.

Authors:  M Yabe; H Yabe; K Hattori; T Morimoto; T Hinohara; I Takakura; T Shimizu; K Shimamura; X Tang; S Kato
Journal:  Bone Marrow Transplant       Date:  1997-02       Impact factor: 5.483

5.  Natural history of hepatopulmonary syndrome: Impact of liver transplantation.

Authors:  Karen L Swanson; Russell H Wiesner; Michael J Krowka
Journal:  Hepatology       Date:  2005-05       Impact factor: 17.425

6.  Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis.

Authors:  Peter Schenk; Maximilian Schöniger-Hekele; Valentin Fuhrmann; Christian Madl; Gerd Silberhumer; Christian Müller
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

7.  Dyskeratosis Congenita (DC) Registry: identification of new features of DC.

Authors:  S Knight; T Vulliamy; A Copplestone; E Gluckman; P Mason; I Dokal
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

8.  Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome.

Authors:  Eric A Collisson; Hamid Nourmand; Mark H Fraiman; Christopher B Cooper; Paul E Bellamy; Douglas G Farmer; John M Vierling; Rafik M Ghobrial; Ronald W Busuttil
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

9.  Gastrointestinal involvement in a woman with dyskeratosis congenita.

Authors:  K E Brown; T E Kelly; B M Myers
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

10.  Excellent outcome of living donor liver transplantation in patients with hepatopulmonary syndrome: a single centre experience.

Authors:  Sanjiv Saigal; Narendra Choudhary; Neeraj Saraf; Hardik Kotecha; Rahul Kakodkar; Ravi Mohanka; Amit Rastogi; Palat Menon; Sanjay Goja; Deepak Govil; Vijay Vohra; Arvinder Soin
Journal:  Clin Transplant       Date:  2013-05-31       Impact factor: 2.863

View more
  7 in total

Review 1.  Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.

Authors:  Andrew C Dietz; Sharon A Savage; Adrianna Vlachos; Parinda A Mehta; Dorine Bresters; Jakub Tolar; Carmem Bonfim; Jean Hugues Dalle; Josu de la Fuente; Roderick Skinner; Farid Boulad; Christine N Duncan; K Scott Baker; Michael A Pulsipher; Jeffrey M Lipton; John E Wagner; Blanche P Alter
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-19       Impact factor: 5.742

Review 2.  Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.

Authors:  Andrew C Dietz; Parinda A Mehta; Adrianna Vlachos; Sharon A Savage; Dorine Bresters; Jakub Tolar; Farid Boulad; Jean Hugues Dalle; Carmem Bonfim; Josu de la Fuente; Christine N Duncan; K Scott Baker; Michael A Pulsipher; Jeffrey M Lipton; John E Wagner; Blanche P Alter
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-20       Impact factor: 5.742

3.  Disease progression and clinical outcomes in telomere biology disorders.

Authors:  Marena R Niewisch; Neelam Giri; Lisa J McReynolds; Rotana Alsaggaf; Sonia Bhala; Blanche P Alter; Sharon A Savage
Journal:  Blood       Date:  2022-03-24       Impact factor: 25.476

4.  Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase Mutation.

Authors:  Jennifer M Kolb; Kendra Conzen; Michael Wachs; Joseph Crossno; Brandon McMahon; Maheen Z Abidi; Elizabeth A Pomfret; Michael Kriss
Journal:  Hepatology       Date:  2020-07       Impact factor: 17.425

Review 5.  An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Authors:  Marena R Niewisch; Sharon A Savage
Journal:  Expert Rev Hematol       Date:  2019-09-10       Impact factor: 2.819

6.  Dyskeratosis congenita.

Authors:  Lorenzo Gitto; Robert Stoppacher; Timothy Eric Richardson; Serenella Serinelli
Journal:  Autops Case Rep       Date:  2020-09-02

Review 7.  Telomere biology disorders.

Authors:  Michelle L W Kam; Trang T T Nguyen; Joanne Y Y Ngeow
Journal:  NPJ Genom Med       Date:  2021-05-28       Impact factor: 8.617

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.